SEARCH

SEARCH BY CITATION

References

  • 1
    Ordentlich P. Pharmacodynamic analysis of ENCORE 301, a placebo-controlled, randomized phase 2 study of exe-mestane with and without entinostat in postmenopausal ER+ breast cancer patients demonstrates an association of lysine hyperacetylation with clinical outcome. Abstract PR-6. AACR Molecular Targets and Cancer Therapeutics Meeting, November 2011.
  • 2
    Robertson FM. Gene amplification of anaplastic lymphoma kinase in inflammatory breast cancer. Abstract PR-4. AACR Molecular Targets and Cancer Therapeutics Meeting, November 2011.
  • 3
    Bacus S. KRAS mutation and amplification status predicts sensitivity to antifolate therapies in non-small cell lung cancer. Abstract PR-2. AACR Molecular Targets and Cancer Therapeutics Meeting, November 2011.